BC in the News
Synthon: Benelux Deal of the Year – Real Deals
We are proud to share that BC Partners has been named winner of the ‘Benelux Deal of the Year’ award…
News & Insights
Discover our latest insights and keep up to date with BC Partners’ news.
Featured
VideoBC Insights
Biogaran: : video case study
At the start of this year, BC Partners, alongside Bpifrance, completed the acquisition of Biogaran – a major player in…
BC InsightsVideo
IGS: video case study
IGS GeboJagema is the leading independent healthcare manufacturer in the tooling market for medical devices — and one of…
Latest
VideoBC Insights
Biogaran: : video case study
At the start of this year, BC Partners, alongside Bpifrance, completed the acquisition of Biogaran – a major player in…
BC in the News
Synthon: Benelux Deal of the Year – Real Deals
We are proud to share that BC Partners has been named winner of the ‘Benelux Deal of the Year’ award…
BC InsightsVideo
PetLabCo: video case study
In 2025, BC Partners acquired a majority stake in premium animal health brand PetLabCo. With a strong track record in…
Press Release
BC Partners and Bpifrance confirm the completion of the acquisition of Biogaran
BC Partners, a leading European investment firm, and Bpifrance, the French public investment bank, today announce the completion of the…
Press Release
Servier and BC Partners enter exclusive negotiations for the sale of Biogaran
BC Partners is excited to support Biogaran in building a French-headquartered, industry-leading supplier of high-quality generic medication. Leveraging its deep…
Press Release
BC Partners to invest in IGS GeboJagema in partnership with management and Smile Invest
IGS GeboJagema (“IGS”) (www.igsgebojagema.nl), the leading independent healthcare manufacturer in the tooling market for medical devices, announces, together with its…
Press Release
BC Partners acquires a majority stake in premium animal health brand PetLab Co.
Investment leverages BC Partners’ expertise in the pet sector, building on its successful investments in Chewy, PetSmart, VetPartners and Antelliq.…
BC in the News
FT: Goldman Sachs’ investment arm agrees €2bn deal for drugmaker Synthon
Goldman Sachs Asset Management has agreed a more than €2bn deal to acquire drugmaker Synthon from BC Partners, according to…
Press Release
BC Partners agrees to sell majority stake in Synthon to Goldman Sachs Alternatives
Under BC Partners’ active ownership, Synthon has expanded rapidly, more than doubling EBITDA Transaction maintains BC Partners’ momentum in realisations,…